Presepsin: gelsolin ratio, as a promising marker of sepsis-related organ dysfunction: a prospective observational study

被引:3
作者
Ragan, Daniel [1 ,2 ]
Kustan, Peter [1 ]
Horvath-Szalai, Zoltan [1 ,3 ]
Szirmay, Balazs [1 ]
Miseta, Attila [1 ]
Woth, Gabor [2 ,4 ]
Koszegi, Tamas [1 ,3 ,5 ]
Muhl, Diana [2 ]
机构
[1] Univ Pecs, Dept Lab Med, Med Sch, Pecs, Hungary
[2] Univ Pecs, Dept Anesthesiol & Intens Therapy, Med Sch, Pecs, Hungary
[3] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary
[4] Klin Ottakring, Dept Anesthesia Intens Care & Pain Med, Vienna, Austria
[5] Univ Pecs, Natl Lab Human Reprod, Pecs, Hungary
关键词
sepsis-3; organ dysfunction; prognosis; presepsin; gelsolin; gelsolin ratio; novel biomarker; SEPTIC SHOCK; PLASMA GELSOLIN; BIOMARKERS; MORTALITY; SYSTEM; TRENDS; CARE;
D O I
10.3389/fmed.2023.1126982
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction We aimed to facilitate the diagnosis and prognosis of sepsis-related organ dysfunction through analyzing presepsin (PSEP) and gelsolin (GSN) levels along with a novel marker, the presepsin:gelsolin (PSEP:GSN) ratio.Methods Blood samples were collected from septic patients at the intensive care unit (ICU) at three time points (T1-3): T1: within 12 h after admission; T2: second day morning; T3: third day morning. Sampling points for non-septic ICU patients were T1 and T3. PSEP was measured by a chemiluminescence-based POCT method while GSN was determined by an automated immune turbidimetric assay. Data were compared with routine lab and clinical parameters. Patients were categorized by the Sepsis-3 definitions. PSEP:GSN ratio was evaluated in major sepsis-related organ dysfunctions including hemodynamic instability, respiratory insufficiency and acute kidney injury (AKI).Results In our single center prospective observational study, 126 patients were enrolled (23 control, 38 non-septic and 65 septic patients). In contrast to controls, significantly elevated (p < 0.001) admission PSEP:GSN ratios were found in non-septic and septic patients. Regarding 10-day mortality prediction, PSEP:GSN ratios were lower (p < 0.05) in survivors than in non-survivors during follow-up, while the prognostic performance of PSEP:GSN ratio was similar to widely used clinical scores (APACHE II, SAPS II, SOFA). PSEP:GSN ratios were also higher (p < 0.001) in patients with sepsis-related AKI than septic non-AKI patients during follow-up, especially in sepsis-related AKI patients needing renal replacement therapy. Furthermore, increasing PSEP:GSN ratios were in good agreement (p < 0.001) with the dosage and the duration of vasopressor requirement in septic patients. Moreover, PSEP:GSN ratios were markedly greater (p < 0.001) in patients with septic shock than in septic patients without shock. Compared to septic patients requiring oxygen supplementation, substantially elevated (p < 0.001) PSEP:GSN ratios were observed in septic patients with demand for mechanical ventilation, while higher PSEP:GSN ratios (p < 0.001) were also associated with extended periods of mechanical ventilation requirement in septic patients.Conclusion PSEP:GSN ratio could be a useful complementary marker besides the routinely used SOFA score regarding the diagnosis and short term mortality prediction of sepsis. Furthermore, the significant increase of this biomarker may also indicate the need for prolonged vasopressor or mechanical ventilation requirement of septic patients. PSEP:GSN ratio could yield valuable information regarding the extent of inflammation and the simultaneous depletion of the patient's scavenger capacity during sepsis.Clinical trail registration NIH U.S. National Library of Medicine, . Trial identifier: NCT05060679, () 23.03.2022, Retrospectively registered.
引用
收藏
页数:11
相关论文
共 43 条
  • [31] Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study
    Rudd, Kristina E.
    Johnson, Sarah Charlotte
    Agesa, Kareha M.
    Shackelford, Katya Anne
    Tsoi, Derrick
    Kievlan, Daniel Rhodes
    Colombara, Danny V.
    Ikuta, Kevin S.
    Kissoon, Niranjan
    Finfer, Simon
    Fleischmann-Struzek, Carolin
    Machado, Flavia R.
    Reinhart, Konrad K.
    Rowan, Kathryn
    Seymour, Christopher W.
    Watson, R. Scott
    West, T. Eoin
    Marinho, Fatima
    Hay, Simon I.
    Lozano, Rafael
    Lopez, Alan D.
    Angus, Derek C.
    Murray, Christopher J. L.
    Naghavi, Mohsen
    [J]. LANCET, 2020, 395 (10219) : 200 - 211
  • [32] Presepsin and prognostic nutritional index are predictors of septic acute kidney injury, renal replacement therapy initiation in sepsis patients, and prognosis in septic acute kidney injury patients: a pilot study
    Shimoyama, Yuichiro
    Umegaki, Osamu
    Kadono, Noriko
    Minami, Toshiaki
    [J]. BMC NEPHROLOGY, 2021, 22 (01)
  • [33] Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients
    Shirakawa, Kamon
    Naitou, Katsuki
    Hirose, Jirou
    Takahashi, Tomohiro
    Furusako, Shoji
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 (05) : 937 - 939
  • [34] Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome
    Shozushima, Tatsuyori
    Takahashi, Gaku
    Matsumoto, Naoya
    Kojika, Masahiro
    Okamura, Yoshikazu
    Endo, Shigeatsu
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (06) : 764 - 769
  • [35] The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
    Singer, Mervyn
    Deutschman, Clifford S.
    Seymour, Christopher Warren
    Shankar-Hari, Manu
    Annane, Djillali
    Bauer, Michael
    Bellomo, Rinaldo
    Bernard, Gordon R.
    Chiche, Jean-Daniel
    Coopersmith, Craig M.
    Hotchkiss, Richard S.
    Levy, Mitchell M.
    Marshall, John C.
    Martin, Greg S.
    Opal, Steven M.
    Rubenfeld, Gordon D.
    van der Poll, Tom
    Vincent, Jean-Louis
    Angus, Derek C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (08): : 801 - 810
  • [36] Epidemiology of severe sepsis: 2008-2012
    Stoller, Jeremy
    Halpin, Laura
    Weis, Matthew
    Aplin, Brett
    Qu, Weikai
    Georgescu, Claudiu
    Nazzal, Munier
    [J]. JOURNAL OF CRITICAL CARE, 2016, 31 (01) : 58 - 62
  • [37] Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis
    Suhler, E
    Lin, W
    Yin, HL
    Lee, WM
    [J]. CRITICAL CARE MEDICINE, 1997, 25 (04) : 594 - 598
  • [38] Diagnostic accuracy of procalcitonin and in patients with acute kidney injury
    Takahashi, Gaku
    Shibata, Shigehiro
    Fukui, Yasuo
    Okamura, Yoshikazu
    Inoue, Yoshihiro
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2016, 86 (02) : 205 - 210
  • [39] Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study
    Ulla, Marco
    Pizzolato, Elisa
    Lucchiari, Manuela
    Loiacono, Maria
    Soardo, Flavia
    Forno, Daniela
    Morello, Fulvio
    Lupia, Enrico
    Moiraghi, Corrado
    Mengozzi, Giulio
    Battista, Stefania
    [J]. CRITICAL CARE, 2013, 17 (04)
  • [40] Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis
    Velissaris, Dimitrios
    Zareifopoulos, Nicholas
    Karamouzos, Vasileios
    Karanikolas, Evangelos
    Pierrakos, Charalampos
    Koniari, Ioanna
    Karanikolas, Menelaos
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (05)